Pegvisomant
Records for this ingredient, by country (identity only).
ATC H01AX01 · 7 markets · 32 records
AU 7 records · 3 shown of 3
- 20 mg per mL / per unit basis not statedinjectionSOMAVERTSOMAVERT pegvisomant (rbe) 10mg powder for injection vial and diluent in pre-filled syringe
- 15 mg per mL / per unit basis not statedinjectionSOMAVERTSOMAVERT pegvisomant (rbe) 10mg powder for injection vial and diluent in pre-filled syringe
- 10 mg per mL / per unit basis not statedinjectionSOMAVERTSOMAVERT pegvisomant (rbe) 10mg powder for injection vial and diluent in pre-filled syringe
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 5 records · 5 shown of 5
- 20 mg per mL / per unit basis not statedinjectionSomavert 10mg powder and solvent for solution for injection vials
- 15 mg per mL / per unit basis not statedinjectionSomavert 10mg powder and solvent for solution for injection vials
- 10 mg per mL / per unit basis not statedinjectionSomavert 10mg powder and solvent for solution for injection vials
- 30 mg per mL / per unit basis not statedinjectionSomavert 10mg powder and solvent for solution for injection vials
- 25 mg per mL / per unit basis not statedinjectionSomavert 10mg powder and solvent for solution for injection vials
CA 5 records · 5 shown of 5
ES 5 records · 5 shown of 5
FR 5 records · 5 shown of 5
- 20 mg per mL / per unit basis not statedinjectionSOMAVERT 10 mg, poudre et solvant pour solution injectable
- 15 mg per mL / per unit basis not statedinjectionSOMAVERT 10 mg, poudre et solvant pour solution injectable
- 10 mg per mL / per unit basis not statedinjectionSOMAVERT 10 mg, poudre et solvant pour solution injectable
- 30 mg per mL / per unit basis not statedinjectionSOMAVERT 10 mg, poudre et solvant pour solution injectable
- 25 mg per mL / per unit basis not statedinjectionSOMAVERT 10 mg, poudre et solvant pour solution injectable
JP 3 records · 3 shown of 3
- 20 mg per mL / per unit basis not statedinjectionソマバート皮下注用20mg
- 15 mg per mL / per unit basis not statedinjectionソマバート皮下注用20mg
- 10 mg per mL / per unit basis not statedinjectionソマバート皮下注用20mg
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | GB | CA | AU | ES | JP | EU | FR |
|---|---|---|---|---|---|---|---|
| 20 mg per mL / per unit basis not stated cannot compare injection | Somavert 10mg powder and solvent for solution for injection vials | SOMAVERT SOMAVERT pegvisomant (rbe) 10mg powder for injection vial and diluent in pre-filled syringe | SOMAVERT | ソマバート皮下注用20mg | SOMAVERT 10 mg, poudre et solvant pour solution injectable | ||
| 15 mg per mL / per unit basis not stated cannot compare injection | Somavert 10mg powder and solvent for solution for injection vials | SOMAVERT SOMAVERT pegvisomant (rbe) 10mg powder for injection vial and diluent in pre-filled syringe | SOMAVERT | ソマバート皮下注用20mg | SOMAVERT 10 mg, poudre et solvant pour solution injectable | ||
| 10 mg per mL / per unit basis not stated cannot compare injection | Somavert 10mg powder and solvent for solution for injection vials | SOMAVERT SOMAVERT pegvisomant (rbe) 10mg powder for injection vial and diluent in pre-filled syringe | SOMAVERT | ソマバート皮下注用20mg | SOMAVERT 10 mg, poudre et solvant pour solution injectable | ||
| 30 mg per mL / per unit basis not stated cannot compare injection | Somavert 10mg powder and solvent for solution for injection vials | SOMAVERT | SOMAVERT 10 mg, poudre et solvant pour solution injectable | ||||
| 25 mg per mL / per unit basis not stated cannot compare injection | Somavert 10mg powder and solvent for solution for injection vials | SOMAVERT | SOMAVERT 10 mg, poudre et solvant pour solution injectable | ||||
| 30 mg per mL / per unit basis not stated cannot compare liquid | SOMAVERT | ||||||
| 25 mg per mL / per unit basis not stated cannot compare liquid | SOMAVERT | ||||||
| 20 mg per mL / per unit basis not stated cannot compare liquid | SOMAVERT | ||||||
| 15 mg per mL / per unit basis not stated cannot compare liquid | SOMAVERT | ||||||
| 10 mg per mL / per unit basis not stated cannot compare liquid | SOMAVERT | ||||||
unknown | SOMAVERT | SOMAVERT |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.